Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split [Yahoo! Finance]